Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2016
Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2
Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2016 Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2016" provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Continuous Glucose Monitoring Systems under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons to buy The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 3
- Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product s current stage of development, territory and estimated launch date Additional Details Publisher : Global Data Reference : GDME0292EPD Number of Pages : 264 Report Format : PDF Publisher Information : 4
Table Of Contents for Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2016 1 Table of Contents1 Table of Contents 21.1 List of Tables 71.2 List of Figures 162 Introduction 172.1 Continuous Glucose Monitoring Systems Overview 173 Products under Development 183.1 Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development 183.2 Continuous Glucose Monitoring Systems - Pipeline Products by Territory 193.3 Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path 203.4 Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date 213.5 Continuous Glucose Monitoring Systems - Ongoing Clinical Trials 224 Continuous Glucose Monitoring Systems - Pipeline Products under Development by Companies 234.1 Continuous Glucose Monitoring Systems Companies - Pipeline Products by Stage of Development 234.2 Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development 275 Continuous Glucose Monitoring Systems Companies and Product Overview 315.1 A. Menarini Diagnostics S.r.l. Company Overview 315.2 Abbott Diabetes Care, Inc. Company Overview 335.3 Advanced Biosensors-Ohio, Llc Company Overview 355.4 Advanced Medical Electronics Corporation Company Overview 365.5 Alcon Inc Company Overview 385.6 Arkal Medical, Inc. Company Overview 395.7 Azurite Technologies, Inc. Company Overview 415.8 Bar-Ilan University Company Overview 425.9 Bellco Srl Company Overview 435.10 Bio-Impedance General Ltd. Company Overview 445.11 Biorasis, Inc. Company Overview 455.12 BioTex Inc Company Overview 465.13 Biovotion AG Company Overview 475.14 Brigham and Women's Hospital Company Overview 495.15 CALISTO MEDICAL, INC. (Inactive) Company Overview 505.16 Cardiff University Company Overview 515.17 CGM3 Ltd Company Overview 525.18 ConvaTec Healthcare B Sarl Company Overview 535.19 Cyber Medical Ltd. Company Overview 545.20 Debiotech SA Company Overview 565.21 DexCom Inc Company Overview 585.22 DirectSens GmbH Company Overview 705.23 Eccrine Systems Inc Company Overview 715.24 Echo Therapeutics Inc Company Overview 725.25 Ecole Polytechnique Federale de Lausanne Company Overview 765.26 elutions Integrated Systems, Inc. Company Overview 775.27 EyeSense GmbH Company Overview 785.28 Flowsion A/S Company Overview 825.29 Globe Medical Tech Inc Company Overview 845.30 GlucoLight Corporation Company Overview 855.31 Glucometrics, Inc. Company Overview 865.32 Glucometrix AG Company Overview 875.33 Glucosense Diagnostics Ltd Company Overview 885.34 GlucoSet AS Company Overview 895.35 Glucovation Inc Company Overview 905.36 GluMetrics Inc Company Overview 915.37 Glusense Ltd Company Overview 925.38 GlySens Inc Company Overview 935.39 GlySure Ltd Company Overview 975.40 G-Sense Ltd. Company Overview 1005.41 Guided Therapeutics Inc Company Overview 1015.42 Hypo-Safe A/S Company Overview 1035.43 iglyko, Inc. Company Overview 1065.44 Institute of Biomedical Engineering (ISIB-CNR) (Inactive) Company Overview 1085.45 Insulet Corp Company Overview 1095.46 Integrity Applications Ltd Company Overview 1115.47 Invivomon Inc. Company Overview 1145.48 Invivosense ASA Company Overview 1155.49 isense Corporation (Inactive) Company Overview 1165.50 Luminous Medical Inc Company Overview 1175.51 Massachusetts Institute of Technology Company Overview 1195.52 MASTInc Company Overview 1205.53 Medella Health Inc. Company Overview 1215.54 Medical Wireless Sensing Ltd Company Overview 1225.55 Medtronic plc Company Overview 1245.56 Mellitor Ltd. Company Overview 1325.57 Microchips Biotech Inc Company Overview 1335.58 mobilife Company Overview 1345.59 Nemaura Medical Inc Company Overview 1355.60 Northwestern University Company Overview 1375.61 NovioSense B.V. Company Overview 1395.62 Optiscan Biomedical Corp Company Overview 1415.63 Pignolo SpA Company Overview 1445.64 PositiveID Corp Company Overview 1455.65 Prediktor AS Company Overview 1475.66 Profusa, Inc. Company Overview 1495.67 Roche Diagnostics International Ltd Company Overview 1505.68 San Meditech (Huzhou) Co., Ltd. Company Overview 1525.69 Senseonics, Incorporated Company Overview 1535.70 SensiVida Medical Technologies, Inc. (Inactive) Company Overview 1565.71 Senzime AB Company Overview 1575.72 Singapore Biomicro Pte Ltd Company Overview 1595.73 Stanford University Company Overview 1605.74 Tenax Therapeutics Inc Company Overview 1615.75 Terumo Corp Company Overview 1625.76 The Charles Stark Draper Laboratory Inc Company Overview 1645.77 Ultradian Diagnostics LLC Company Overview 1665.78 University of Bari Aldo Moro Company Overview 1685.79 University of Bath Company Overview 1695.80 University of California Berkeley Company Overview 1705.81 University of California San Diego Company Overview 1725.82 University of South Florida Company Overview 1745.83 University of Strathclyde Company Overview 1755.84 University of Texas at Arlington Company Overview 1765.85 Vytrace, Inc. Company Overview 1775.86 Zyvex Corporation Company Overview 1786 Continuous Glucose Monitoring Systems- Recent Developments 1796.1 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 1796.2 Nov 5
21, 2016: PositiveID Reports Revenue of $4.6 Million for First Nine Months of 2016, Up 70% from $2.7 Million for First Nine Months of 2015 1816.3 Nov 18, 2016: Abbott Labs Prices Public Offering of 2.35% Notes due 2019 for USD2.9 Billion 1826.4 Nov 18, 2016: Abbott Labs Prices Public Offering of 2.9% Notes due 2021 for USD2.85 Billion 1826.5 Nov 18, 2016: Abbott Labs Prices Public Offering of 3.4% Notes due 2023 for USD1.5 Billion 1836.6 Nov 18, 2016: Abbott Labs Prices Public Offering of 3.75% Notes due 2026 for USD3 Billion 1836.7 Nov 18, 2016: Abbott Labs Prices Public Offering of 4.9% Notes due 2046 for USD3.3 Billion 1846.8 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 1846.9 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 1846.10 Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ 1856.11 Nov 11, 2016: Presentation of PRECISE II U.S. Pivotal Trial Data of the Eversense CGM System at the 16th Annual Diabetes Technology Meeting 1866.12 Nov 11, 2016: GlucoTrack Maker to Present Updated Scientific Data Demonstrating Increased Accuracy 1876.13 Nov 10, 2016: Tenax Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update 1876.14 Nov 07, 2016: GlucoTrack Maker Announces Receipt of Final Regulatory Approval in South Korea 1886.15 Nov 03, 2016: Insulet Reports Third Quarter 2016 Financial Results 1896.16 Nov 02, 2016: Henry Schein Reports Record Third Quarter Financial Results 1906.17 Nov 01, 2016: DexCom Reports Third Quarter 2016 Financial Results 1926.18 Nov 01, 2016: Tandem Diabetes Care Reports Third Quarter 2016 Financial Results 1936.19 Oct 27, 2016: Senseonics submits Eversense Continuous Glucose Monitoring system PMA to FDA 1946.20 Oct 26, 2016: ConvaTec Raises USD1.8 Billion in IPO 1956.21 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 1956.22 Oct 24, 2016: NovioSense Raises Funds in Venture Financing 1976.23 Oct 19, 2016: PositiveID to Present at RedChip's Global Online Growth Conference on October 20th 1976.24 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 1976.25 Sep 28, 2016: Abbott Receives FDA Approval for the FreeStyle Libre Pro System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients 2006.26 Sep 27, 2016: PositiveID Announces Highlights for Third Quarter 2016 2016.27 Sep 15, 2016: PositiveID to Present at the 2016 Aegis Growth Conference on September 22nd 2026.28 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 2026.29 Sep 07, 2016: Completed The First Subject in Clinical Study for Continuous Glucose Monitoring System in Hong Kong 2036.30 Sep 07, 2016: Reimbursement of Dexcom CGM Technology for Patients with Type 1 and Type 2 Insulin-Dependent Diabetes is Now Available in Germany 2046.31 Sep 06, 2016: Insulet Raises Private Placement of Senior Notes for USD300 Million 2046.32 Sep 06, 2016: Insulet to Establish Highly-Automated Manufacturing Operation in the United States 2056.33 Sep 06, 2016: Insulet Announces Executive Appointments 2056.34 Sep 01, 2016: Medtronic Announces Approval Of Enlite Sensor For ipro2 Professional Continuous Glucose Monitoring System In The U.S. 2056.35 Aug 25, 2016: M Pharma Raises USD1.5 Million in First Tranche of Private Placement of 10% Debentures Due 2019 2066.36 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 2066.37 Aug 25, 2016: Lee's Pharmaceutical Holdings: Interim Results For The Six Months Ended 30 June 2016 2096.38 Aug 17, 2016: Guided Therapeutics Reports Second Quarter 2016 Financial Results; Year to Date Revenue Up 71% Over Same Period Last Year 2116.39 Aug 15, 2016: PositiveID Reports Q2 2016 Revenue of $1.8 Million, Up from $51 Thousand in Q2 2015 2126.40 Aug 12, 2016: Echo Therapeutics Announces Second Quarter 2016 Financial Results 2136.41 Aug 11, 2016: Tenax Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update 2146.42 Aug 09, 2016: Senseonics Reports Topline Accuracy Results from U.S. Pivotal Study of Eversense CGM System 2156.43 Aug 04, 2016: Nemaura Medical, Completes Second FDA Pre-submission Meeting And Appoints Navigant To Submit IDE For Nemauras SugarBEAT System 2166.44 Aug 04, 2016: Henry Schein Reports Second Quarter Financial Results 2166.45 Aug 03, 2016: Insulet Reports Second Quarter 2016 Financial Results 2186.46 Aug 02, 2016: DexCom Reports Second Quarter 2016 Financial Results 2196.47 Jul 28, 2016: Tandem Diabetes Care Reports Second Quarter 2016 Financial Results 2196.48 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 2216.49 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 2226.50 Jul 19, 2016: FDA Posts Briefing Documents Ahead of Advisory Committee Meeting 2246.51 Jul 19, 2016: Medtronic Expands Continuous Glucose Monitoring Solutions for People with Diabetes Using Insulin Injections with CE Mark Receipt 2256.52 Jul 12, 2016: PositiveID Announces Highlights for First Half of 2016 2266.53 Jul 08, 2016: Ossen Innovation to Acquire 90.27% Stake in San MediTech from America-Asia Diabetes Research Foundation 2267 Appendix 2597.1 Methodology 2597.2 About GlobalData 2627.3 Contact Us 2627.4 Disclaimer 262 6
List Of Tables in Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2016 1.1 List of Tables Table 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development 20 Table 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory 21 Table 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path 22 Table 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date 23 Table 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials 24 Table 6: Continuous Glucose Monitoring Systems Companies - Pipeline Products by Stage of Development 25 Table 7: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development 29 Table 8: A. Menarini Diagnostics S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 33 Table 9: GlucoMen Day - Product Status 33 Table 10: GlucoMen Day - Product Description 34 Table 11: Abbott Diabetes Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35 Table 12: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Status 35 Table 13: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Description 36 Table 14: Advanced Biosensors-Ohio, Llc Pipeline Products & Ongoing Clinical Trials Overview 37 Table 15: Continuous Glucose Monitor - Product Status 37 Table 16: Continuous Glucose Monitor - Product Description 37 Table 17: Advanced Medical Electronics Corporation Pipeline Products & Ongoing Clinical Trials Overview 38 Table 18: Continuous Glucose Monitor - Product Status 38 Table 19: Continuous Glucose Monitor - Product Description 39 Table 20: Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 40 Table 21: Smart Contact Lens - Diabetes - Product Status 40 Table 22: Smart Contact Lens - Diabetes - Product Description 40 Table 23: Arkal Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41 Table 24: GlucoPod CGM System - Product Status 41 Table 25: GlucoPod CGM System - Product Description 42 Table 26: Azurite Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43 Table 27: Blood Glucose Sensor - Product Status 43 7
Table 28: Blood Glucose Sensor - Product Description 43 Table 29: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 44 Table 30: Biometric Watch - Product Status 44 Table 31: Biometric Watch - Product Description 44 Table 32: Bellco Srl Pipeline Products & Ongoing Clinical Trials Overview 45 Table 33: Low Frequency Electromagnetic Glucose Sensor - Product Status 45 Table 34: Low Frequency Electromagnetic Glucose Sensor - Product Description 45 Table 35: Bio-Impedance General Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46 Table 36: MD Watch - Product Status 46 Table 37: MD Watch - Product Description 46 Table 38: Biorasis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47 Table 39: Glucowizzard - Product Status 47 Table 40: Glucowizzard - Product Description 47 Table 41: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 48 Table 42: Smart Tattoo Glucose Sensor - Product Status 48 Table 43: Smart Tattoo Glucose Sensor - Product Description 48 Table 44: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 49 Table 45: Multisensor Glucose Monitoring System - Product Status 49 Table 46: Multisensor Glucose Monitoring System - Product Description 49 Table 47: VSM 3 Glucose Monitoring System - Product Status 50 Table 48: VSM 3 Glucose Monitoring System - Product Description 50 Table 49: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 51 Table 50: Fluorescence Measurement Device - Product Status 51 Table 51: Fluorescence Measurement Device - Product Description 51 Table 52: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 52 Table 53: Glucoband - Product Status 52 Table 54: Glucoband - Product Description 52 Table 55: Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 53 Table 56: Non-Invasive Blood Glucose Meter - Product Status 53 Table 57: Non-Invasive Blood Glucose Meter - Product Description 53 Table 58: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 54 8
Table 59: CGM Sensor - Product Status 54 Table 60: CGM Sensor - Product Description 54 Table 61: ConvaTec Healthcare B Sarl Pipeline Products & Ongoing Clinical Trials Overview 55 Table 62: Closed Loop Continuous Glucose Monitoring System - Product Status 55 Table 63: Closed Loop Continuous Glucose Monitoring System - Product Description 55 Table 64: Cyber Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56 Table 65: Cybersensors Continuous Glucose Sensor - Product Status 56 Table 66: Cybersensors Continuous Glucose Sensor - Product Description 57 Table 67: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 58 Table 68: Integrated isense CGM And JewelPUMP - Product Status 58 Table 69: Integrated isense CGM And JewelPUMP - Product Description 59 Table 70: DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 60 Table 71: DexCom CGM With Accu-Chek Insulin Delivery System - Product Status 60 Table 72: DexCom CGM With Accu-Chek Insulin Delivery System - Product Description 61 Table 73: Dexcom G4 PLATINUM Continuous Glucose Monitor - Product Status 61 Table 74: Dexcom G4 PLATINUM Continuous Glucose Monitor - Product Description 62 Table 75: GlucoClear - Product Status 62 Table 76: GlucoClear - Product Description 63 Table 77: GlucoClear - Second Generation - Product Status 63 Table 78: GlucoClear - Second Generation - Product Description 63 Table 79: Next-Generation Continuous Glucose Monitoring (CGM) Device - Product Status 64 Table 80: Next-Generation Continuous Glucose Monitoring (CGM) Device - Product Description 64 Table 81: DexCom Inc - Ongoing Clinical Trials Overview 65 Table 82: GlucoClear - Second Generation - Pilot Observation of Continuous Glucose Monitoring in Critically Ill Patients Under Consideration of Accuracy, Feasibility and Acceptance by Ward Staff 67 Table 83: Dexcom G4 PLATINUM Continuous Glucose Monitor - A Single-blind, Randomized, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy and Dual-hormone Closed-loop Strategy at Preventing Hypoglycemia During Unannounced and Announced Exercise in Adults with Type 1 Diabetes 67 Table 84: Dexcom G4 PLATINUM Continuous Glucose Monitor - A Single-center, Prospective, 'Open-label', Investigator-initiated Pilot Study Evaluating the Role of Continuous Glucose Monitor (CGM) Use Either Alone or with Remote Monitoring Capabilities 68 Table 85: Dexcom G4 PLATINUM Continuous Glucose Monitor - An Open-label, Randomized, Two-way, Cross-over Multicenter Study to Assess the Efficacy of Closed-loop Strategy as Compared to Multiple Daily Injections in Regulating Glucose Levels During 24 Hours in Adults with Type 2 Diabetes under Intensive Insulin Th 68 9
Table 86: Dexcom G4 PLATINUM Continuous Glucose Monitor - Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects 69 Table 87: Dexcom G4 PLATINUM Continuous Glucose Monitor - Long-term Effects of Continuous Glucose Monitoring in Patients with Type 1 Diabetes Treated with Multiple Daily Insulin Injections - Extension of CGMMDI Trial 69 Table 88: Dexcom G4 PLATINUM Continuous Glucose Monitor - Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient with Diabetes and Chronic Kidney Disease - Validation Study 69 Table 89: Dexcom G4 PLATINUM Continuous Glucose Monitor - Real-time Continuous Glucose Monitoring (RT- CGM) in Patients with Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY) 70 Table 90: Dexcom G4 PLATINUM Continuous Glucose Monitor - Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2 70 Table 91: Dexcom G4 PLATINUM Continuous Glucose Monitor - The Monitoring Study: Evaluating the Effect of Remote Monitoring For Hypoglycemia on Bionic Pancreas Safety and Efficacy 71 Table 92: Dexcom G4 PLATINUM Continuous Glucose Monitor - Use of Zone-Model Predictive Control (MPC) Controller on the Diabetes Assistant (DiAs) Platform with Fault Detection in Adolescents with Type 1 Diabetes in the Outpatient Setting (UCSB Study) 71 Table 93: DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview 72 Table 94: Continuous Blood Glucose Monitoring System - Product Status 72 Table 95: Continuous Blood Glucose Monitoring System - Product Description 72 Table 96: Eccrine Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 73 Table 97: Sweatronics Electronic Patch - Product Status 73 Table 98: Sweatronics Electronic Patch - Product Description 73 Table 99: Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 74 Table 100: Gen 2 Symphony CGM System - Product Status 74 Table 101: Gen 2 Symphony CGM System - Product Description 75 Table 102: NextGen System - Product Status 75 Table 103: NextGen System - Product Description 75 Table 104: Symphony tcgm System - Home - Product Status 76 Table 105: Symphony tcgm System - Home - Product Description 76 Table 106: Symphony tcgm System - Hospital Critical Care - Product Status 77 Table 107: Symphony tcgm System - Hospital Critical Care - Product Description 77 Table 108: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 78 Table 109: Viscosimetric Sensor - Product Status 78 Table 110: Viscosimetric Sensor - Product Description 78 Table 111: elutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79 10
Table 112: Optically-Efficient Miniaturized Raman Optical System - Product Status 79 Table 113: Optically-Efficient Miniaturized Raman Optical System - Product Description 79 Table 114: EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview 80 Table 115: Eye Sensor - Product Status 80 Table 116: Eye Sensor - Product Description 81 Table 117: Fiber Optic Sensor - Product Status 81 Table 118: Fiber Optic Sensor - Product Description 82 Table 119: EyeSense GmbH - Ongoing Clinical Trials Overview 83 Table 120: Fiber Optic Sensor - Clinical Study for Continuous Glucose Monitoring System in Hong Kong 83 Table 121: Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 84 Table 122: Diramo System - Product Status 84 Table 123: Diramo System - Product Description 85 Table 124: Globe Medical Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 86 Table 125: Continuous Glucose Monitoring Device - Product Status 86 Table 126: Continuous Glucose Monitoring Device - Product Description 86 Table 127: GlucoLight Corporation Pipeline Products & Ongoing Clinical Trials Overview 87 Table 128: SENTRIS-100 - Product Status 87 Table 129: SENTRIS-100 - Product Description 87 Table 130: Glucometrics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88 Table 131: Portable Blood Glucose Meter - Product Status 88 11
List Of Figures, Charts and Diagrams in Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2016 1.2 List of Figures Figure 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development 20 Figure 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory 21 Figure 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path 22 Figure 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date 23 Figure 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials 24 12
How to Buy... Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2016 Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $4000 Single User Price $8000 Site License Price $12000 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 13